[1] Belli L, Galimberti R, Negroni R. et al. Treatment of tinea corporis or tinea cruris with bifonazule 1% gel:an open multicentre study. Pharmatherapeutica.1985,4:106.
[2] Belli L, CGalimberti R, Negroni R, et al. Treatment of superficial candidiasis with bifonazole 1% gel. Pharmathera-peutica,1985,4:102.
[3] Clerico R, Cantorese F, Bianchi D, et al. A new topical antifungal agent, bifonazole, in pityriasis versicolor. Dermatol Clin,l985,5:79.
[4] Glimberti R. Belli L; Gatti JC, et al. An open, multicentre assessment of the effectiveness of b:tonazole in the treatment of tines(pttyrtasts)versicolor. Pharmather. peutica,1985,4:109.
[5] Glimberti R,Belli L,Negroni R.et al. Treatment of tines-pedis interdigitalis with bifonazole, 1% gel. Dermatologica,1984.169(Suppll):111.
[6] Lasosevic J, Ro jas R, Astorga E, et al. Bifonazole cream in the treatment of superficial candidiasis:a double-blincl comparative study. Dermatologica. 1984, 159 (Suppl 1):99.
[7] Robert DT, Adriaans B. Gentles JC. A comparative study of once daily bifonazole cream versus twice daily miconazole cream in the treatment of tines pedis. Mykosen, 1985,28:550.
[8] Shulter G. Toxicology of bifonazole. Arzneimittelforschung 1983,33:739.
[9] Uchida K, Yamashita S, Yamaguchi H. Antibacterial acrivity of bifonazole against aerobic and anaerobic bacteria. Chemotherapy(Tokyo) 1984.32:825.
[10] Palacio A, Lopez-Suso MJ, Moore MK, et al. Long-term follow-up of otomycosis and its treatment with bifonazole.J Med Veter Mycoloqy.1993,31:435. |
